- Home
- CB vs BSX Comparison
CB vs BSX Comparison
Compare CB & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CB
- BSX
- Stock Information
- Founded
- CB 1985
- BSX 1979
- Country
- CB Switzerland
- BSX United States
- Employees
- CB N/A
- BSX N/A
- Industry
- CB Property-Casualty Insurers
- BSX Medical/Dental Instruments
- Sector
- CB Finance
- BSX Health Care
- Exchange
- CB Nasdaq
- BSX Nasdaq
- Market Cap
- CB 114.2B
- BSX 129.7B
- IPO Year
- CB 1993
- BSX 1992
- Fundamental
- Price
- CB $273.24
- BSX $89.09
- Analyst Decision
- CB Buy
- BSX Strong Buy
- Analyst Count
- CB 20
- BSX 23
- Target Price
- CB $289.00
- BSX $96.41
- AVG Volume (30 Days)
- CB 1.7M
- BSX 5.1M
- Earning Date
- CB 01-28-2025
- BSX 01-29-2025
- Dividend Yield
- CB 1.33%
- BSX N/A
- EPS Growth
- CB 44.45
- BSX 47.19
- EPS
- CB 24.43
- BSX 1.21
- Revenue
- CB $54,697,000,000.00
- BSX $15,911,000,000.00
- Revenue This Year
- CB N/A
- BSX $17.67
- Revenue Next Year
- CB $6.63
- BSX $12.68
- P/E Ratio
- CB $11.18
- BSX $73.58
- Revenue Growth
- CB 13.16
- BSX 15.66
- 52 Week Low
- CB $220.21
- BSX $55.60
- 52 Week High
- CB $302.05
- BSX $91.93
- Technical
- Relative Strength Index (RSI)
- CB 36.80
- BSX 46.40
- Support Level
- CB $271.28
- BSX $89.49
- Resistance Level
- CB $277.82
- BSX $91.59
- Average True Range (ATR)
- CB 4.62
- BSX 1.40
- MACD
- CB -0.86
- BSX -0.35
- Stochastic Oscillator
- CB 11.45
- BSX 23.79
About CB Chubb Limited
ACE acquired Chubb in the first quarter of 2016 and assumed the Chubb name. The combination made the new Chubb one of the largest domestic property and casualty insurers, with operations in 54 countries spanning commercial and personal P&C insurance, reinsurance, and life insurance.
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.